ARTL (STOCKS)
Artelo Biosciences, Inc. Common Stock
$0.750000
+0.017000 (+2.32%)
Prev close: $0.733000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Gregory D. Gorgas
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $2.71M
- Employees
- 6
- P/E (TTM)
- -0.02
- P/B (TTM)
- 0.10
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
3
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.89 | $0.00 | +0.0000 | +0.00% |
|
Dec 2025 (Q4)
|
$-0.12 | $-4.80 | +4.6842 | +97.50% |
|
Sep 2025 (Q3)
|
$-11.91 | $-2.51 | -9.4008 | -374.65% |
|
Jun 2025 (Q2)
|
$-16.83 | $-12.82 | -4.0086 | -31.26% |
Financial Statements
| Assets | $12.52M |
| Current Assets | $10.42M |
| Noncurrent Assets | $2.10M |
| Intangible Assets | $2.04M |
| Other Non-current Assets | $58.00K |
| Liabilities | $5.85M |
| Current Liabilities | $5.83M |
| Noncurrent Liabilities | $18.00K |
| Equity | $6.67M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $6.67M |
| Liabilities And Equity | $12.52M |